Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment.
10.1016/j.antiviral.2018.05.001 Pu et al. Antiviral Res. Cited 9 times
Pu S, Xiao F, Schor S, Bekerman E, Zanini F, Barouch-Bentov R, Nagamine CM, Einav S
Study details